The Clinical Potential of Renin Inhibitors and Angiotensin Antagonists
- 1 April 1994
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 47 (4) , 586-598
- https://doi.org/10.2165/00003495-199447040-00003
Abstract
No abstract availableKeywords
This publication has 87 references indexed in Scilit:
- Renin system inhibition. Beginning the fourth epoch.Circulation, 1992
- Design and synthesis of potent, selective, and orally active fluorine-containing renin inhibitorsJournal of Medicinal Chemistry, 1992
- Substrate analog renin inhibitors containing replacements of histidine in P2 or isosteres of the amide bond between P3 and P2 sitesJournal of Medicinal Chemistry, 1991
- Potential role of the tissue renin-angiotensin system in the pathophysiology of congestive heart failureThe American Journal of Cardiology, 1990
- Nonpeptide angiotensin II receptor antagonists. Studies with EXP9270 and DuP 753.Hypertension, 1990
- Differentiation of Angiotensin–Converting Enzyme (ACE) Inhibitors by Their Selective Inhibition of ACE in Physiologically Important Target OrgansAmerican Journal of Hypertension, 1989
- Why renin inhibitors?Journal Of Hypertension, 1989
- A carboxy-terminus truncated analog of angiotensin II, [Sar1]angiotensin II-(1-7)-amide, provides an entry to a new class of angiotensin II antagonistsJournal of Medicinal Chemistry, 1989
- Renin gene expression, biosynthesis, and cellular pathways of secretion.1988
- H-77: a potent new renin inhibitor. In vitro and in vivo studies.Hypertension, 1982